Research ArticleClinical Studies

Predictive Biological Markers for Response of Invasive Breast Cancer to Anthracycline / Cyclophosphamide-based Primary (Radio-)Chemotherapy

HANS-BERND PRISACK, CHRISTIAAN KARREMAN, OLGA MODLICH, WERNER AUDRETSCH, MAHMOUD DANAE, MAHADI REZAI and HANS BOJAR
Anticancer Research November 2005, 25 (6C) 4615-4621;

Article Information

vol. 25 no. 6C 4615-4621
PubMed 
16334152
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 12, 2005
  • Accepted July 1, 2005
  • Published online November 1, 2005.
Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. HANS-BERND PRISACK1,
  2. CHRISTIAAN KARREMAN1,
  3. OLGA MODLICH1,
  4. WERNER AUDRETSCH2,
  5. MAHMOUD DANAE1,
  6. MAHADI REZAI3 and
  7. HANS BOJAR1
  1. 1Department of Chemical Oncology, University of Düsseldorf, Düsseldorf
  2. 2Comprehensive Breast Center Düsseldorf, Gräulinger Str. 120 D-40625 Düsseldorf
  3. 3Luisenkrankenhaus Düsseldorf, Degerstr. 8 D-40235 Düsseldorf, Germany
  1. Correspondence to: Dr. Hans Bernd Prisack, Department of Chemical Oncology, Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany. Tel: +49-211-811-4302, Fax: +49-211-811-5114, e-mail: Hans-Bernd.Prisack{at}uni-duesseldorf.de

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Predictive Biological Markers for Response of Invasive Breast Cancer to Anthracycline / Cyclophosphamide-based Primary (Radio-)Chemotherapy
HANS-BERND PRISACK, CHRISTIAAN KARREMAN, OLGA MODLICH, WERNER AUDRETSCH, MAHMOUD DANAE, MAHADI REZAI, HANS BOJAR
Anticancer Research Nov 2005, 25 (6C) 4615-4621;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section